Showing results (2321-2330 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|September 1, 1991
Brodimoprim versus amoxicillin in the treatment of acute sinusitisR Nyffenegger, D Riebenfeld, A MacciocchiClinical Therapeutics|September 1, 1991
Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfateM Coplin, S Schuette, G Leichtmann, et al.Clinical Therapeutics|September 11, 1991
Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitusA J Garber, J A Davidson, A Krosnick, et al.Clinical Therapeutics|June 20, 2007
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group studyJochen Graff, Mohammed Arabmotlagh, Raymond Cheung, et al.Clinical Therapeutics|June 20, 2007
Health care resource utilization and expenditures associated with the use of insulin glargineDonald R Miller, John A Gardner, Ann M Hendricks, et al.Clinical Therapeutics|June 20, 2007
An evaluation of patients' preferences for osteoporosis medications and their attributes: the PREFER-International studyJesús Walliser Duarte, Susan C Bolge, Shuvayu S SenClinical Therapeutics|December 6, 2007
Fabry disease model: a rational approach to the management of Fabry diseaseChristoph WannerClinical Therapeutics|August 19, 2007
Dosing of insulin glargine in the treatment of type 2 diabetesAnthony BarnettClinical Therapeutics|August 19, 2007
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhalerKevin Murphy, Michael Noonan, Philip E Silkoff, et al.Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokersMasakazu Nakamura, Akira Oshima, Yoko Fujimoto, et al.Pageof 680